liposomal PC5

Liposomal PC5 refers to a liposomal formulation designed to deliver inhibitors or genetic modulators (such as siRNA) targeting **Proprotein Convertase 5** (PC5, also known as PCSK5). PC5 is a member of the proprotein convertase family responsible for the proteolytic activation of various precursor proteins, including viral glycoproteins and growth factors. In the context of infectious diseases, such as HIV-1, PC5 is involved in the processing of the envelope glycoprotein gp160 into gp120 and gp41, which is essential for viral infectivity. Liposomal delivery is utilized to enhance the stability and cellular uptake of PC5 inhibitors, particularly in lymphoid tissues where viral replication is prominent. Research has explored these formulations as potential therapeutic strategies to block viral maturation and reduce viral load.

Other names

liposomal proprotein convertase 5 inhibitorPC5-liposomesPC-5-liposomesPC 5-liposomes